XML 23 R9.htm IDEA: XBRL DOCUMENT v2.3.0.15
Related Party
9 Months Ended
Sep. 30, 2011
Related Party
2.    Related Party

Based on its stock ownership in the Company, MD Anderson Cancer Center meets the criteria to be deemed a related party of Bio-Path Holdings.  In the third quarter ending September 30, 2011, MD Anderson received $25,000 in cash from the Company for patent expenses previously accrued and related to the Company’s Technology License, plus an additional $50,000 in expense was accrued for R&D related clinical trial expense.  As of September 30, 2011, the Company had accrued expenses due to the related party totaling $150,000, comprised of $50,000 in accrued license payments related to the Company’s Technology License and $100,000 in accrued R&D related expense for the clinical trial.  See Note 6.